Abstract
Introduction: Dacomitinib is a second-generation epidermal growth factor receptor tyrosine kinase inhibitor (EGFR TKI). Recent results from ARCHER 105......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
